Heparin Market Analysis in South Korea Region: Role of Heparin Drugs in Medicine


Heparin Market Overview:

Drugs are often given to the patient just before a surgery to decrease the chances of blood clot formation. Heparin, a glycosaminoglycan, is one of such drugs that is anti-coagulant and can be used as a blood thinner as it is able to keep the blood liquid and prevent blood clot formation in arteries, veins as well as lungs. Therefore, it is used to treat a various health problems including deep vein thrombosis, acute coronary syndrome, pulmonary embolism, atrial fibrillation, cardiopulmonary bypass, hemofiltration during cardiac surgery, and major orthopedic procedures such as hip and knee replacements.

According to a report published by Allied Market Research, the global heparin market size is projected to reach $11.01 billion with a considerable CAGR from 2021 to 2028. The Asia-Pacific region is expected to manifest the fastest growth rate, owing to growth in healthcare infrastructure in developing countries, rise in initiatives by public & private organizations, economic development, presence of untapped resources, and many other factors.

Request for Sample Report for More Insights@ https://www.alliedmarketresearch.com/request-sample/6551

Impact of COVID-19 Pandemic on Heparin Market:

Moreover, the outbreak of COVID-19 pandemic led to have a positive impact on the growth of the global heparin market, owing to rise in demand for heparin. A large number of COVID-19 patients suffer from respiratory syndrome. As a result, the demand for heparin has increased as it helps to tackle respiratory inflation and thin the blood of those at risk of a blood clot. Most of the COVID-19 patients were treated with prophylactic dose low molecular weight heparin during the pandemic.

Furthermore, the demand of heparin is anticipated to rise significantly with the increase in the aging population, which in turn, is going to boost the growth of the global heparin market even more. With this drift on board, the key market players are expanding their geographical presence in the emerging economies to gather high market share. At the same time, the availability of synthetic and semi-synthetic heparin mimetic that help to treat cancer, coagulation, and inflammatory diseases is offering lucrative opportunities for heparin adoption. Here, it is worth mentioning that the global heparin market has a huge scope to capture exponential growth in the years to come.

Post a Comment